TITLE

Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy

AUTHOR(S)
Ha, Hong Il; Kim, Ah Young; Yu, Chang Sik; Park, Seong Ho; Ha, Hyun Kwon
PUB. DATE
December 2013
SOURCE
European Radiology;Dec2013, Vol. 23 Issue 12, p3345
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: To evaluate DW MR tumour volumetry and post-CRT ADC in rectal cancer as predicting factors of CR using high b values to eliminate perfusion effects. Methods: One hundred rectal cancer patients who underwent 1.5-T rectal MR and DW imaging using three b factors (0, 150, and 1,000 s/mm 2) were enrolled. The tumour volumes of T2-weighted MR and DW images and pre- and post-CRT ADC 150–1000 were measured. The diagnostic accuracy of post-CRT ADC, T2-weighted MR, and DW tumour volumetry was compared using ROC analysis. Results: DW MR tumour volumetry was superior to T2-weighted MR volumetry comparing the CR and non-CR groups ( P < 0.001). Post-CRT ADC showed a significant difference between the CR and non-CR groups ( P = 0.001). The accuracy of DW tumour volumetry (A z = 0.910) was superior to that of T2-weighed MR tumour volumetry (A z = 0.792) and post-CRT ADC (A z = 0.705) in determining CR ( P = 0.015). Using a cutoff value for the tumour volume reduction rate of more than 86.8 % on DW MR images, the sensitivity and specificity for predicting CR were 91.4 % and 80 %, respectively. Conclusion: DW MR tumour volumetry after CRT showed significant superiority in predicting CR compared with T2-weighted MR images and post-CRT ADC. Key Points: • Diffusion-weighted MR (DWMR) imaging offers new information about rectal cancer.• DWMR helps to predict complete remission after chemoradiotherapy in patients with advanced rectal cancer.• DWMR provides more accurate diagnostic information than T2-weighted MRI.• Apparent diffusion coefficients can predict CR, but they have certain clinical limitations.
ACCESSION #
91929848

 

Related Articles

  • The Difficulty with Localization of Rectal Cancer after Neoadjuvant Chemoradiation Therapy. TORRES, MARLA L.; McCAFFERTY, MICHAEL H.; JORDEN, JEFFREY // American Surgeon;Sep2010, Vol. 76 Issue 9, p974 

    Neoadjuvant chemoradiation therapy (NCRT) has become the standard treatment for locally advanced rectal cancer. Subsequent downstaging can make identification of the primary tumor challenging. Complete pathologic response rates of 8 per cent to 27 per cent are seen with current NCRT regimen. Two...

  • Irinotecan+5-fluorouracil with concomitant pre-operative radiotherapy in locally advanced non-resectable rectal cancer: a phase I/II study. Iles, S M; Gollins, S W; Susnerwala, S; Haylock, B; Myint, S; Biswas, A; Swindell, R; Levine, E; Iles, Sm; Gollins, Sw // British Journal of Cancer;3/24/2008, Vol. 98 Issue 7, p1210 

    In the UK, 10% of patients diagnosed with rectal cancer have inoperable disease at presentation. This study ascertained whether the resectability rate of inoperable locally advanced rectal cancer was improved by administration of intravenous irinotecan, 5-fluorouracil (5-FU) and pelvic...

  • A observational study of the efficacy and safety of capecitabine versus bolus infusional 5-fluorouracil in pre-operative chemoradiotherapy for locally advanced rectal cancer. Chen, Chin-Fan; Huang, Ming-Yii; Huang, Chih-Jen; Wu, Chan-Han; Yeh, Yung-Sung; Tsai, Hsiang-Lin; Ma, Cheng-Jen; Lu, Chien-Yu; Chang, Shun-Jen; Chen, Ming-Jenn; Wang, Jaw-Yuan // International Journal of Colorectal Disease;Jun2012, Vol. 27 Issue 6, p727 

    Background and objectives: This study is to evaluate the safety and efficacy of preoperative radiotherapy (RT) combined with bolus infusional 5-fluorouracil (5-FU) or oral capecitabine in patients with locally advanced rectal cancer (LARC). Materials and methods: Seventy-four patients were...

  • Correlations Between Intratumoral Microvessel Density and Histopathological Type or Neoadjuvant Radiotherapy for Rectal Carcinoma. DUMITRESCU, T.; USCATU, C. D.; ALEXANDRU, D. O.; MEŞINĂ, C.; MOGOANTĂ, S. Ş.; DINCĂ, ILEANA; MORARU, E.; DUMITRESCU, ALEXANDRA; GHEONEA, D. I.; NICOLI, RALUCA ELENA; VASILE, I. // Current Health Sciences Journal;Apr-Jun2015, Vol. 41 Issue 2, p152 

    Purpose: This study aims to evaluate intratumoral microvessel density in rectal carcinoma cases with different histopathological type (adenocarcinoma and mucinous carcinoma) and different preoperatory neoadjuvant radiotherapy status (irradiated / non-irradiated), thus analyzing any possible...

  • Neo-adjuvant chemo-radiation of rectal cancer with Volumetric Modulated Arc Therapy: summary of technical and dosimetric features and early clinical experience. Richetti, Antonella; Fogliata, Antonella; Clivio, Alessandro; Nicolini, Giorgia; Pesce, Gianfranco; Salati, Emanuela; Vanetti, Eugenio; Cozzi, Luca // Radiation Oncology;2010, Vol. 5, p14 

    Background: To report about initial technical and clinical experience in preoperative radiation treatment of rectal cancer with volumetric modulated arcs with the RapidArc® (RA) technology. Methods: Twenty-five consecutive patients (pts) were treated with RA. All showed locally advanced...

  • Previous transanal endoscopic microsurgery for rectal cancer represents a risk factor for an increased abdominoperineal resection rate. Morino, Mario; Allaix, Marco; Arolfo, Simone; Arezzo, Alberto // Surgical Endoscopy;Sep2013, Vol. 27 Issue 9, p3315 

    Background: Transanal endoscopic microsurgery (TEM) represents a surgical option in the treatment of selected early rectal cancers. However, when definitive histopathology shows negative prognostic factors, rectal resection with total mesorectal excision (TME) is recommended to reduce the risk...

  • Radiotherapy for localized rectal cancer. Deutsch, E; Ezra, P; Mangoni, M; Ducreux, M // Annals of Oncology;Sep2007 Supplement 9, Vol. 18, pix105 

    The article discusses the use of radiotherapy in the treatment of localized rectal cancer. The treatment options for rectal cancer includes total mesorectal excision (TME), radiotherapy and chemotherapy. The article describes the clinical indication for short- or long-term radiation therapy for...

  • Multidisciplinary treatment of rectal cancer: medical oncology. Aschele, C; Lonardi, S // Annals of Oncology;Sep2007 Supplement 9, Vol. 18, pix114 

    The article discusses the multidisciplinary treatment of rectal cancer. It emphasizes the relevance of multidisciplinary approach to the clinical management of rectal cancer. It explains how patients with rectal cancer are selected for adjuvant treatment. In addition, the article also discusses...

  • The Use of Pelvic Radiation in Stage II Rectal Cancer: A Population-Based Analysis. KUO, ISABELLA; WONG, JAN H.; ROY-CHOWDHURY, SHARMILA; LUM, SHARON S.; MORGAN, JOHN W.; KAZANJIAN, KEVORK // American Surgeon;Oct2010, Vol. 76 Issue 10, p1092 

    National Institutes of Health (NIH) guidelines recommend the use of pelvic radiation in T3N0 rectal cancer. We sought to determine the rate of compliance with NIH radiation guidelines for patients with T3N0 rectal cancer. We performed a retrospective cohort study of T3N0 rectal cancer diagnosed...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics